During this webinar, Truveris pharmacy experts discuss how expanding GLP-1 indications and a growing pipeline of new drugs are increasing GLP-1 coverage expectations.
In this webinar, we look at:
- GLP-1 market trends in 2026
- Access channel analysis (PBM models vs direct-to-employer (DTE) and direct-to-consumer (DTC) alternatives)
- Carve-in and carve-out approaches
- Lifestyle management models
- Compounded GLP-1 updates
- Coverage decision making frameworks
Learning Objectives
- Understand the forces driving GLP-1 cost and demand growth: Gain insight into how expanding indications and a growing drug pipeline are increasing utilization and the eligible population, and what this means for long-term plan spend.
- Compare GLP-1 access channel strategies: Assess the tradeoffs between PBM, DTE, and DTC channels, including pricing structure, rebate impact, and new administrative complexity.
- Evaluate the risks of compounded GLP-1 drugs: Learn the key due diligence questions employers should ask compounding pharmacies and telehealth vendors to avoid safety and legal exposure.
Watch: 2026 GLP-1 Coverage Strategies
